PriceTargets.com logo

TSE:CARE - Dialogue Health Technologies Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$7.00
  • Forecasted Upside: 72.84 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$4.05 As of 05/25/2022 01:00 AM ET
▲ +0.22 (5.74%)

This chart shows the closing price for CARE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Dialogue Health Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CARE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CARE

Analyst Price Target is C$7.00
▲ +72.84% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Dialogue Health Technologies in the last 3 months. The average price target is C$7.00, with a high forecast of C$0.00 and a low forecast of C$0.00. The average price target represents a 72.84% upside from the last price of C$4.05.

This chart shows the closing price for CARE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 investment analysts is to hold stock in Dialogue Health Technologies.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/29/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/25/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
5/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/13/2022Royal Bank of CanadaLower Price TargetSector PerformC$10.00 ➝ C$7.00
5/12/2022CIBCLower Price TargetOutperformC$9.50 ➝ C$7.00
5/12/2022ScotiabankLower Price TargetC$11.00 ➝ C$8.50
5/11/2022TD SecuritiesDowngradeBuy ➝ HoldC$8.50 ➝ C$5.50
(Data available from 5/26/2017 forward)

News Sentiment Rating

-0.49 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
5/26/2022

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.

Dialogue Health Technologies

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance, and occupational health and safety programs. It serves employers and organizations. Dialogue Technologies Inc. was founded in 2016 and is headquartered in Montreal, Canada.
Read More

Today's Range

Now: C$4.05
Low: C$3.83
High: C$4.34

50 Day Range

MA: N/A

52 Week Range

Now: C$4.05
Low: C$3.65
High: C$13.00

Volume

104,330 shs

Average Volume

74,700 shs

Market Capitalization

C$266.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Dialogue Health Technologies?

The following Wall Street research analysts have issued stock ratings on Dialogue Health Technologies in the last year: CIBC, Royal Bank of Canada, Scotiabank, and TD Securities.
View the latest analyst ratings for CARE.

What is the current price target for Dialogue Health Technologies?

0 Wall Street analysts have set twelve-month price targets for Dialogue Health Technologies in the last year. Their average twelve-month price target is C$7.00, suggesting a possible upside of 72.8%.
View the latest price targets for CARE.

What is the current consensus analyst rating for Dialogue Health Technologies?

Dialogue Health Technologies currently has 2 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CARE, but not buy more shares or sell existing shares.
View the latest ratings for CARE.